To obtain greater goods decision makers often have to incur and endure costs. Here we review mechanisms that enhance the willingness to accept and overcome costs in individual and social settings. General, cost-invariant mechanisms involve controlling and reducing reward-related impulsivity, abstracting from personal and situational circumstances, changing the availability of options in the choice set, and reinterpreting aspects of the choice alternatives. These mechanisms are based on fronto-striatal and fronto-parietal networks for valuation and goal-setting. More specific, costvariant mechanisms include effort endurance, imagining future events, tolerating risk, and empathy. These mechanisms rely on cost-specific brain mechanisms, as well as interactions with the valuation network in accordance with cost-variant changes in the valuation of the costly choice alternatives. We identify knowledge gaps, which are exacerbated by studies typically focusing only on one cost type. Moreover, many of the identified mechanisms of enduring costs provide largely untrodden paths for interventions to increase cost endurance in clinical and non-clinical domains.
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Introduction
Goal directed actions and value-based decision making rely on implementing the course of action or choosing the choice alternative with the best balance between subjective costs and subjective benefits. With typical valuebased decisions, the alternatives with greater benefits are also more costly. Accordingly, when decision makers experience a trade-off between high cost, high benefit versus low cost, low benefit alternatives (Table 1) , they may follow paths of less resistance and choose alternatives with smaller costs. As the choice of the more costly alternative may be in some sense better for the decision maker or desired by society, the question arises whether and how the willingness to accept costs and the capacity to endure them can be increased so that agents obtain greater goods. Here we address this question with a focus on psychological and neural mechanisms, reviewing mostly human imaging and transcranial stimulation studies. For methodological reasons, these stimulation studies typically are limited to the cortex and neglect subcortical brain regions, whereas a review of single cell recording and optogenetic stimulation studies would concentrate more on subcortical structures.
Costs come in different forms, such as effort, time, risk, and selfishness. Although the modalities of these costs differ, their subjective value can be measured experimentally with generic currencies such as money in humans or juice in animals. For this review, we propose a classification scheme that distinguishes cost-invariant (domain-general) from cost-variant (domain-specific) approaches to increasing cost endurance. Cost-invariant mechanisms can be used to tilt the cost-benefit balance in the direction of higher cost, higher benefit alternatives irrespective of the type of costs or to sculpt the choice space such that lower cost, lower benefit alternatives are less likely to be chosen. Cost-variant approaches subjectively modify the properties of specific cost types. For example, practicing a particular type of effort would reduce the perceived cost of exerting this effort but typically not generalize to increased willingness of enduring other types of costs. It should be kept in mind though that the assignment of findings to cost-invariant and costvariant categories remains somewhat tentative in several cases, simply because the question has not been investigated yet as studies often look at only one rather than multiple cost types.
At the neural level, cost-invariant routes to tilting the cost-benefit balance in favor of cost endurance for greater goods involve regions that process value irrespective of outcome type such as the striatum and the ventromedial prefrontal cortex (VMPFC). We consider also mechanisms that reduce reward-related impulsivity, that is, the temptation to give in to selecting low cost, low benefit alternatives, implemented by dorsolateral prefrontal cortex (DLPFC); mechanisms that facilitate viewing costly choice alternatives from a more distanced perspective, 
